The Scientist

» clinical trials

Most Recent

image: CRISPR Trial for Cancer Patients Proposed

CRISPR Trial for Cancer Patients Proposed

By Katarina Zimmer | January 19, 2018

US researchers could become the first outside China to use the gene-editing technique in the clinic. 

0 Comments

The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials.

0 Comments

image: Can Young Stem Cells Make Older People Stronger?

Can Young Stem Cells Make Older People Stronger?

By Shawna Williams | December 11, 2017

Small trials using younger donors and elderly recipients hint that mesenchymal stem cell transfers might reduce frailty. 

0 Comments

The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.

0 Comments

image: Antiviral Immunotherapy Comes of Age

Antiviral Immunotherapy Comes of Age

By Lucas Laursen | December 4, 2017

T-cell therapies are not just for cancer. Researchers are also advancing immunotherapy methods to protect bone marrow transplant patients from viral infections. 

0 Comments

image: New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

New CAR T-Cell Therapy Shows Promise in Trial for Leukemia

By Katarina Zimmer | November 21, 2017

The immunotherapy, which targets CD22 on cancer cells rather than CD19, might prove useful in patients for whom previous T-cell treatments were unsuccessful. 

0 Comments

image: Man Receives First In Vivo Gene-Editing Therapy

Man Receives First In Vivo Gene-Editing Therapy

By Kerry Grens | November 15, 2017

The 44-year-old patient has Hunter syndrome, which doctors hope to treat using zinc finger nucleases.

0 Comments

image: Equivocal Findings of Alzheimer’s Trial Using Young Blood

Equivocal Findings of Alzheimer’s Trial Using Young Blood

By Catherine Offord | November 6, 2017

A team of Stanford University researchers say that administering young people’s blood plasma to Alzheimer’s patients could improve cognitive function, but the results have been criticized.

0 Comments

If approved, patisiran will be the first RNAi therapeutic on the market. 

0 Comments

image: FDA Goes After Two Stem Cell Clinics

FDA Goes After Two Stem Cell Clinics

By Kerry Grens | August 29, 2017

The agency raided one that was using a stem cell-smallpox vaccine combo, and sent a warning to another to obey best practices.

0 Comments

Popular Now

  1. How to Separate the Science From the (Jerk) Scientist
  2. Could a Dose of Sunshine Make You Smarter?
  3. Prevalent Form of Childhood Leukemia May Be Preventable
  4. Conservation Biologist Ben Collen Dies of Bone Cancer